AI start­up grabs $60M, un­veils plat­form aimed at drug dis­cov­ery's 'da­ta prob­lem'

As the com­pu­ta­tion­al tools for drug dis­cov­ery pro­lif­er­ate, it can start to feel like an ar­ti­fi­cial in­tel­li­gence or ma­chine learn­ing play­er is en­ter­ing the fray every oth­er week. But no mat­ter how so­phis­ti­cat­ed those al­go­rithms are, some­thing could still be miss­ing.

That’s ac­cord­ing to Ter­ray Ther­a­peu­tics, which is join­ing the par­ty with $60 mil­lion af­ter three years in stealth mode and bring­ing with it not just soft­ware but hard­ware that it de­scribes as a chem­istry en­gine op­er­at­ing at mas­sive scale.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER